GlassScriptPhysician profile
John R Valvo
NPI 1043235138
$42,442.10
in general payments reported to CMS, 2019-2025
36 companies · $15K in 2025
The $15K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $656 · 2020: $13K · 2021: $777 · 2022: $2,382 · 2023: $11K · 2024: $306 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $1,786 · Travel and Lodging: $1,239 · Education: $26.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,572.24 |
| Food and Beverage | $1,786.34 |
| Travel and Lodging | $1,239.16 |
| Education | $26.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $27,130.30 | 2020-2025 | |
| Intuitive Surgical, INC. | $12,595.03 | 2019-2023 | Da Vinci Surgical System |
| Olympus America INC. | $400.57 | 2019-2024 | Itind System |
| Janssen Biotech, INC. | $265.80 | 2019-2022 | |
| Astellas Pharma US INC | $200.10 | 2019-2022 | |
| Teleflex LLC | $160.93 | 2021-2024 | Urolift |
| Ethicon INC. | $159.94 | 2021 | |
| Procept Biorobotics Corporation | $143.94 | 2023 | Aquabeam Robotic System |
| Medtronic, INC. | $122.33 | 2021-2024 | Interstim |
| Boston Scientific Corporation | $114.37 | 2021-2023 | Lithovue |
| Pfizer INC. | $108.14 | 2019-2022 | |
| Coloplast Corp | $94.90 | 2022-2024 | Speedicath |
| Urogen Pharma, INC. | $94.86 | 2021-2023 | Jelmyto |
| Organogenesis INC. | $94.00 | 2019 | |
| Neotract INC. | $81.26 | 2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $69.40 | 2019-2023 | Botox |
| Merck Sharp & Dohme LLC | $61.46 | 2022-2023 | Lynparza, Welireg, Keytruda |
| Medtronic USA, INC. | $59.41 | 2019-2020 | |
| Baxter Healthcare | $54.48 | 2024 | Floseal |
| Sumitomo Pharma America, INC. | $51.01 | 2023 | Gemtesa |
| Myovant Sciences INC. | $48.26 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $44.92 | 2024 | Bard Urinary Drainage Bag |
| Rochester Medical Corporation | $30.14 | 2019 | |
| Osiris Therapeutics INC. | $29.82 | 2019 | |
| Ferring Pharmaceuticals INC. | $26.38 | 2024 | Adstiladrin |
| Dentsply Ih Ab | $25.78 | 2023 | Lofric |
| 180 Medical, INC. | $24.89 | 2023 | Gentlecath Glide |
| Allergan, INC. | $23.36 | 2019 | |
| Dendreon Pharmaceuticals LLC | $22.68 | 2020 | |
| Amgen INC. | $19.97 | 2020 | |
| Agiliti Surgical, INC. | $16.86 | 2023 | Sonablate, Soltive |
| Myriad Genetic Laboratories, INC. | $14.95 | 2020 | |
| Clarus Therapeutics INC. | $14.23 | 2021 | |
| Antares Pharma, INC. | $13.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.80 | 2019 | |
| Cook Medical LLC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Valvo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.